Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

In India, a call to halt financial incentives for stent use
FierceMedicalDevice
Wednesday, January 30, 2013 - 5:46pm
tags:
India, stent, devices, international
Industry coughs up $97M in first medical device tax payment
FierceMedicalDevice
Wednesday, January 30, 2013 - 5:46pm
tags:
device tax, devices, tax
Medtronic Completes Strategic Investment in LifeTech Scientific Corporation
Yahoo/Reuters
Wednesday, January 30, 2013 - 5:41pm
tags:
Medtronic, investment, LifeTech Scientific
Mercantile Court in Spain Rules in ZELTIQ® Aesthetics Patent Infringement Lawsuit Against Clinipro
Yahoo/BusinessWire
Wednesday, January 30, 2013 - 5:40pm
tags:
legal, lawsuit, Spain, Zeltiq, patient, international, devices
Epocrates Inc. (EPOC) is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties
Yahoo/BusinessWire
Wednesday, January 30, 2013 - 5:39pm
tags:
Epocrates, investigation, legal, devices
RTI Biologics Earnings Are on Deck
The Motley Fool
Wednesday, January 30, 2013 - 5:39pm
tags:
RTI Biologics, earnings, devices
Stryker Increases Dividends, Expands In China
Seeking Alpha
Wednesday, January 30, 2013 - 5:38pm
tags:
Stryker, dividend, stock, China, devices
Medtronic Initiates Clinical Study
Yahoo/Zacks
Wednesday, January 30, 2013 - 5:34pm
tags:
Medtronic, clinical study, research, devices
Align Technology Announces Fourth Quarter and Record Fiscal Year 2012 Results
Yahoo/MarketWire
Wednesday, January 30, 2013 - 5:33pm
tags:
Align Technology, earnings, Device
Cardiovascular Systems Reports Fiscal 2013 Second-Quarter Financial Results
Yahoo/BusinessWire
Wednesday, January 30, 2013 - 5:32pm
tags:
Cardiovascular, earnings, devices
Encision Launches Three New Products, Including the EM3 AEM® Monitor
Yahoo/PRNewswire
Wednesday, January 30, 2013 - 5:27pm
tags:
Encision, launch, EM3 AEM, monitoring, devices
Welch Allyn and EarlySense Announce Strategic Collaboration Agreement
Yahoo/BusinessWire
Wednesday, January 30, 2013 - 5:26pm
tags:
Welch Allyn, EarlySense Medical, contract
NeuroMetrix Launches Website for SENSUS™ Pain Management System
Yahoo/BusinessWire
Wednesday, January 30, 2013 - 5:23pm
tags:
NeuroMetrix, launch, website, SENSUS, pain management
Eli Lilly May Have The Best Chance At Keeping The Momentum Going
Seeking Alpha
Wednesday, January 30, 2013 - 4:16pm
tags:
Eli Lilly, Bristol-Myers Squibb, Novo Nordisk, Pfizer, Sanofi
J&J’s Ekdahl Says Hips Recalled Because of Clinical Needs
Bloomberg
Wednesday, January 30, 2013 - 4:05pm
tags:
JNJ, hip implants
Prima BioMed To Get Key Data In Second Half
Seeking Alpha
Wednesday, January 30, 2013 - 1:40pm
tags:
Prima BioMed, Cvac, epithelial ovarian cancer, ovarian cancer
IPE receives FDA approval for Phase 2 clinical trials for BCT303 for hypothyroidism
CP Wire
Wednesday, January 30, 2013 - 1:30pm
tags:
IPE, FDA, BCT303, BCT404, hypothyroidism
Boston Scientific to Cut 1,000 Jobs in Restructuring
Bloomberg
Wednesday, January 30, 2013 - 1:02pm
tags:
layoffs, restructuring, Boston Scientific
Keryx Defies Gravity
Motley Fool
Wednesday, January 30, 2013 - 1:01pm
tags:
Keryx
Forbes Earnings Preview: Gilead Sciences
Forbes
Wednesday, January 30, 2013 - 1:00pm
tags:
earnings, Gilead

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.